Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Changing perceptions by measuring inputs and outputs?

Posted on May 12th, 2017 by

Pharma R&D


Elsevier Reset Therapies 36

Perception is reality. I am sure everyone will have had an experience (or will do so shortly) where their perception of a situation is at odds with the perception of another. We all have our individual styles and preferences. Continue reading “Changing perceptions by measuring inputs and outputs?” »

Overcoming Resistance to Precision Medicines

Posted on May 10th, 2017 by

Pharma R&D

Precision medicine white paper

Precision medicines, which target specific subgroups of patients bearing particular mutations or symptoms, have demonstrated astounding efficacies and have had great success in areas with limited treatment options. Continue reading “Overcoming Resistance to Precision Medicines” »

The Four Cornerstones of a Pharmacovigilance Organization

Posted on May 8th, 2017 by


PV process

For small organizations, building a PV department from the ground up can be an exercise of trial and error, frustrating and costly. Being in growth mode means that there is not much time to anticipate and plan, as multiple high priorities compete for attention. Continue reading “The Four Cornerstones of a Pharmacovigilance Organization” »

Avoiding the Risks of Being Wrong in Drug Discovery

Posted on May 5th, 2017 by

Pharma R&D

pills pic for SD case study

In a recent case study featuring a mid-market biopharma company, a pre-clinical research leader explains that in order to avoid the risks of being wrong when investigating potential new molecules Continue reading “Avoiding the Risks of Being Wrong in Drug Discovery” »

The Drug Works, or Your Money Back – Guaranteed!

Posted on May 3rd, 2017 by

Pharma R&D

Money back guarantee

When we purchase clothes that don’t fit right, we can typically return them to the store for a refund. If your new electronic gadget doesn’t work right, you get your money back. There’s even a brokerage firm that will return fees if a customer isn’t satisfied. Continue reading “The Drug Works, or Your Money Back – Guaranteed!” »

Introducing e-Therapeutics: An In Silico Drug Discovery Lab

Posted on May 1st, 2017 by


Interview with Dr. Jonny Wray

When laypeople think of drug development, they almost certainly imagine clinical labs filled with chemistry and biology labware or trials with control and test groups receiving different doses of the proposed new treatments. Continue reading “Introducing e-Therapeutics: An In Silico Drug Discovery Lab” »

  1. 1
  2. 2
  3. 3
  4. 4
  5. 38

About this Blog


The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.